2019-11-24
研究業績PERFORMANCE
- ホーム
- 研究業績
検索 / SEARCH
[一般学会]
2019-11-24
学会発表
[一般学会]
松村亮, 波多野賢二, 服部功太郎, 宮川友子, 宮下由紀子, 横田悠季, 吉田寿美子, 永井秀明, 後藤雄一: 診療系端末から閲覧可能なバイオバンクポータルサイトの構築. 第39回医療情報学情報連合大会, 幕張, 11.24,2019
2019-08-01
原著
Inoue M, Tanboon J, Okubo M, Theerawat K, Saito Y, Ogasawara M, Indrawati LA, Uruha A, Okiyama N, Fujimoto M, Suzuki S, Nishino I.
Absence of sarcoplasmic MxA expression in antisynthetase syndrome in cohort of 194 cases.
Neuropathol Appl Neurobiol. 2019 Aug;45(5):523-524.
2019-07-01
原著
Onda A, Miyagawa S, Takahashi N, Gochi M, Takagi M, Nishino I, Suzuki S, Oishi C, Yaguchi H.
Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy.
Intern Med. 2019 Jun 1;58(11):1635-1638.
2019-07-01
原著
Nakamura K, Shibuya K, Nishino I, Kuwabara S.
Dropped Head in Sporadic Late-onset Nemaline Myopathy.
Intern Med. 2019 Jul 1;58(13):1967-1968.
2019-06-18
原著
Ikeda M, Takahashi A, Kamatani Y, Momozawa Y, Saito T, Kondo K, Shimasaki A, Kawase K, Sakusabe T, Iwayama Y, Toyota T, Wakuda T, Kikuchi M, Kanahara N, Yamamori H, Yasuda Y, Watanabe Y, Hoya S, Aleksic B, Kushima I, Arai H, Takaki M, Hattori K, Kunugi H, Okahisa Y, Ohnuma T, Ozaki N, Someya T, Hashimoto R, Yoshikawa T, Kubo M, Iwata N.
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
Schizophr Bull. 2019 Jun 18;45(4):824-834.
2019-06-03
原著
Seki M, Uruha A, Ohnuki Y, Kamada S, Noda T, Onda A, Ohira M, Isami A, Hiramatsu S, Hibino M, Nakane S, Noda S, Yutani S, Hanazono A, Yaguchi H, Takao M, Shiina T, Katsuno M, Nakahara J, Matsubara S, Nishino I, Suzuki S.
Inflammatory myopathy associated with PD-1 inhibitors.
J Autoimmun. 2019 Jun;100:105-113.
2019-06-03
原著
Ozawa K, Mochizuki K, Manabe Y, Yoshikura N, Shimohata T, Nishino I, Goto YI.
Reply to: Diagnosing MELAS requires not only an mtDNA variant but also an appropriate phenotype.
Doc Ophthalmol. 2019 Jun;138(3):257-258.
2019-06-02
原著
Mizui T, Hattori K, Ishiwata S, Hidese S, Yoshida S, Kunugi H, Kojima M.
Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia.
J Psychiatr Res. 2019 Jun;113:190-198.
2019-06-01
